-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Artiva Biotherapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q4 2024 to Q3 2025.
- Artiva Biotherapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending September 30, 2025 was $2.28M.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)